NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
Back to search
Official data from USPTO
BIOINX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097374188Class
1, 5, 17, 42, 44
Filing
97374188
Registration
7283167
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/23/2024
Trademark type
Combined
Nice classes
1, 5, 17, 42, 44
Filing date
04/21/2022
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
01
Owner location
Borchtlombeek, BE
Examiner
SALCIDO, JOHN CHARLES
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "BIO" in blue and "INX" in white. Behind the word "INX" is a figurative drop in various shades of blue from bright to dark.
Holders and representatives
Holders
Van Hoorick, Jasper
Representatives
Michael J. Hynak HYNAK & ASSOCIATES, PC
Technical classification
Nice Classes
Class 1Class 5Class 17Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Polymer based compositions used in the field of 3D bioprinting; polymer dispersions for use in the field of 3D bioprinting for a wide variety of goods; Unprocessed polymer compounds for use in manufacture; chemical additives for use in the manufacture of food; chemical additives for use in the manufacture for a wide variety of goods in the biomedical and pharmaceutical fields; chemical preparations for scientific purposes in the biomedical and pharmaceutical fields; biological tissue cultures for industrial purposesother than for medical or veterinary purposes; biological tissue specimens for use in scientific research; collagen based ingredients used as a raw ingredient in the manufacture of cosmetic preparations; biological tissue cultures other than for medical or veterinary purposes; artificial skin for testing cosmetics; All of the aforesaid to be used in the field of 3D printing for biomedical applications
Class 5
Tissue-regenerative pharmaceutical preparations for the treatment of damaged skin and tissue; natural biomaterials for augmentation of bone and tissue for medical purposes; cells for medical or clinical use; Polymer based materials for use in 3D bioprinting for medical use; biological preparations for the treatment of damaged skintissue and bonesskintissue and bone diseases; chemical preparations for pharmaceutical purposesthe treatment of damaged skintissuebonesskintissue and bone diseases; biological implantsa vital processed human or animal connective tissue; pharmaceutical implantsImplantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of damaged skintissue and bonesskintissue and bone diseases
Class 17
Semi-worked thermoplastic filaments used for 3d printing; semi-worked pla filaments for use in 3d printing; semi-worked abs filaments for use in 3d printing; plastic filaments for 3d printing
Class 42
Medical research; laboratory research and testing services in the biomedical and pharmaceutical fields; conducting clinical trials for pharmaceutical products for others; drug discovery services; biomedical research services; pharmaceutical research and development
Class 44
Regenerative medicine services
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2023
PUBO
PUBLISHED FOR OPPOSITION
11/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/04/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/04/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
10/04/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2023
ALIE
ASSIGNED TO LIE
09/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2023
GNRT
NON-FINAL ACTION E-MAILED
02/13/2023
CNRT
NON-FINAL ACTION WRITTEN
02/13/2023
DOCK
ASSIGNED TO EXAMINER
02/08/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2022
NWAP
NEW APPLICATION ENTERED
04/25/2022
Continuous trademark protection
Get notified about every new filing that threatens BIOINX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.